Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Larisa V, Gubareva"'
Autor:
Mira C. Patel, Ha T. Nguyen, Philippe Noriel Q. Pascua, Rongyuan Gao, John Steel, Rebecca J. Kondor, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 7, Pp 1410-1415 (2024)
Since May 2023, a novel combination of neuraminidase mutations, I223V + S247N, has been detected in influenza A(H1N1)pdm09 viruses collected in countries spanning 5 continents, mostly in Europe (67/101). The viruses belong to 2 phylogenetically disti
Externí odkaz:
https://doaj.org/article/9e7ebed5eeff4b359fdc654de6da2cd6
Autor:
Teena Mohan, Ha T. Nguyen, Krista Kniss, Vasiliy P. Mishin, Angiezel A. Merced-Morales, Jennifer Laplante, Kirsten St. George, Patricia Blevins, Anton Chesnokov, Juan A. De La Cruz, Rebecca Kondor, David E. Wentworth, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 7, Pp 1953-1957 (2021)
Four cases of oseltamivir-resistant influenza A(H1N1)pdm09 virus infection were detected among inhabitants of a border detention center in Texas, USA. Hemagglutinin of these viruses belongs to 6B.1A5A-156K subclade, which may enable viral escape from
Externí odkaz:
https://doaj.org/article/c701d0f68a2643d69439b2c796161fca
Autor:
Teena Mohan, Larisa V. Gubareva
Publikováno v:
Cold Spring Harbor perspectives in medicine. 12(1)
The neuraminidase (NA) of influenza A and B viruses plays a distinct role in viral replication and has a highly conserved catalytic site. Numerous sialic (neuraminic) acid analogs that competitively bind to the NA active site and potently inhibit enz
Autor:
Vasiliy P. Mishin, Mira C. Patel, Anton Chesnokov, Juan De La Cruz, Ha T. Nguyen, Lori Lollis, Erin Hodges, Yunho Jang, John Barnes, Timothy Uyeki, Charles T. Davis, David E. Wentworth, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 10, Pp 1969-1972 (2019)
Baloxavir showed broad-spectrum in vitro replication inhibition of 4 types of influenza viruses (90% effective concentration range 1.2–98.3 nmol/L); susceptibility pattern was influenza A ˃ B ˃ C ˃ D. This drug also inhibited influenza A viruses
Externí odkaz:
https://doaj.org/article/f8fd3e4e7d9b409cad2bcbbe53b4b083
Autor:
Krista Kniss, Thomas Rowe, Alicia M Fry, Angela Foust, Sonja J Olsen, Joyce Jones, Wendy Sessions, Alicia P Budd, Angiezel Merced-Morales, Claire M Midgley, Fiona Havers, John Steel, David E. Wentworth, Mila M. Prill, Aron J. Hall, Shikha Garg, C. Todd Davis, Yunho Jang, Peter Daly, Rebecca Kondor, Catherine B. Smith, Larisa V. Gubareva, Benjamin J Silk, John R. Barnes, Amber K Winn, Erin Burns, Lynnette Brammer, Gabriela Jasso
Publikováno v:
American Journal of Transplantation
The COVID-19 pandemic and subsequent implementation of nonpharmaceutical interventions (e.g., cessation of global travel, mask use, physical distancing, and staying home) reduced transmission of some viral respiratory pathogens (1). In the United Sta
Autor:
Krista Kniss, Juan A. De La Cruz, Anton Chesnokov, Larisa V. Gubareva, Angiezel Merced-Morales, Jennifer Laplante, Kirsten St. George, David E. Wentworth, Rebecca Kondor, Teena Mohan, Ha T. Nguyen, Vasiliy P. Mishin, Patricia A. Blevins
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 7, Pp 1953-1957 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
Four cases of oseltamivir-resistant influenza A(H1N1)pdm09 virus infection were detected among inhabitants of a border detention center in Texas, USA. Hemagglutinin of these viruses belongs to 6B.1A5A-156K subclade, which may enable viral escape from
Autor:
Ha T. Nguyen, Tung Nguyen, Vasiliy P. Mishin, Katrina Sleeman, Amanda Balish, Joyce Jones, Adrian Creanga, Henju Marjuki, Timothy M. Uyeki, Dang H. Nguyen, Diep T. Nguyen, Hoa T. Do, Alexander I. Klimov, Charles T. Davis, Larisa V. Gubareva
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 12, Pp 1963-1971 (2013)
We assessed drug susceptibilities of 125 avian influenza A(H5N1) viruses isolated from poultry in Vietnam during 2009–2011. Of 25 clade 1.1 viruses, all possessed a marker of resistance to M2 blockers amantadine and rimantadine; 24 were inhibited b
Externí odkaz:
https://doaj.org/article/02c960cc0676449f80f5883300bf87a0
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 9, Pp 1521-1524 (2013)
Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors,
Externí odkaz:
https://doaj.org/article/93f5b18b81514ca9878bec841a39f8ac
Autor:
Mira C, Patel, Daniel, Flanigan, Chenchen, Feng, Anton, Chesnokov, Ha T, Nguyen, Anwar Abd, Elal, John, Steel, Rebecca J, Kondor, David E, Wentworth, Larisa V, Gubareva, Vasiliy P, Mishin
Publikováno v:
Antiviral Research. 208:105457
Year-round virological characterization of circulating epidemic influenza viruses is conducted worldwide to detect the emergence of viruses that may escape pre-existing immunity or acquire resistance to antivirals. High throughput phenotypic assays a
Autor:
Elena A. Govorkova, Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance D. Presser, Mira C. Patel, Weijuan Huang, Angie Lackenby, Ha T. Nguyen, Dmitriy Pereyaslov, Aine Rattigan, Sook Kwan Brown, Magdi Samaan, Kanta Subbarao, Sun Wong, Dayan Wang, Richard J. Webby, Hui-Ling Yen, Wenqing Zhang, Adam Meijer, Larisa V. Gubareva
Publikováno v:
Antiviral research. 200
Global analysis of the susceptibility of influenza viruses to neuraminidase (NA) inhibitors (NAIs) and the polymerase acidic (PA) inhibitor (PAI) baloxavir was conducted by five World Health Organization Collaborating Centres for Reference and Resear